Declaration of competing financial interests
From the following article
Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases
M Melina Soares, Steven W King & Philip E Thorpe
Nature Medicine 14, 1357 - 1362 (2008) Published online: 23 November 2008
doi:10.1038/nm.1885
Declaration: M.M.S. holds Peregrine Pharmaceuticals Inc. stock, S.W.K. is employed by Peregrine Pharmaceuticals, and P.E.T. is a consultant, stock holder and has sponsored a research agreement with Peregrine Pharmaceuticals. The company is commercially developing bavituximab for the treatment of virus infections.
